Patients' experiences and effects of non-pharmacological treatment for myalgic encephalomyelitis/chronic fatigue syndrome - a scoping mixed methods review. — CFSMEATLAS
Patients' experiences and effects of non-pharmacological treatment for myalgic encephalomyelitis/chronic fatigue syndrome - a scoping mixed methods review.
Mengshoel, Anne Marit, Helland, Ingrid Bergliot, Meeus, Mira et al. · International journal of qualitative studies on health and well-being · 2020 · DOI
Quick Summary
This review looked at 16 European studies on non-drug treatments for ME/CFS, examining what actually helps patients and what matters most to them during treatment. Cognitive behavioral therapy (CBT) showed the most promise for reducing fatigue compared to no treatment, while rehabilitation and activity-pacing approaches showed mixed results. Importantly, patients felt most helped when their doctors truly recognized ME/CFS as a real illness and supported them, but they were often unsure what these treatments actually involved or why they were being recommended.
Why It Matters
This study highlights a critical gap between what treatments are being offered for ME/CFS and what patients actually need or understand about them. By centering patient experiences and emphasizing the need for tailored, well-designed interventions, this review provides evidence that future ME/CFS treatments must be developed with patient input and clearer communication about what they involve and why they matter.
Observed Findings
Cognitive behavioral therapy reduced fatigue scores more than usual care or waiting list controls across 4 studies.
Rehabilitation programs and activity-pacing interventions showed inconsistent effects across included studies.
Patients consistently identified healthcare provider recognition of ME/CFS and supportive therapeutic relationships as essential to treatment.
Patients reported ambiguous or unclear understanding of what non-pharmacological treatments actually involved and their purposes.
Measurement methods, intervention contents, and outcome assessments varied substantially across studies, making direct comparisons impossible.
Inferred Conclusions
CBT may have measurable benefits for fatigue in ME/CFS, though more rigorous research is needed.
Future non-pharmacological treatments must be specifically tailored to address patient-identified concerns and priorities, not just researcher-selected outcomes.
Standardized, patient-centered outcome measures and clearly communicated intervention rationales are essential for bridging the gap between clinical practice and patient understanding.
Remaining Questions
Which specific components of CBT, if any, are responsible for fatigue reduction in ME/CFS?
What This Study Does Not Prove
This review does not establish that these non-pharmacological treatments are definitively effective for ME/CFS, as the studies reviewed had significant methodological differences and inconsistent results. It cannot prove that CBT works through the mechanisms proposed, and mixed results for rehabilitation and activity-pacing mean we cannot conclude whether these approaches benefit or harm patients in the long term. The heterogeneity of studies prevents drawing definitive conclusions about which treatment works best for whom.
Tags
Symptom:Cognitive DysfunctionFatigue
Method Flag:PEM Not DefinedWeak Case DefinitionExploratory OnlyMixed Cohort
Are rehabilitation and activity-pacing approaches actually ineffective, or do current study designs fail to capture their benefits appropriately?
How can healthcare providers better communicate treatment rationales and involve patients in co-designing interventions that align with their lived experiences and concerns?
What do patients consider meaningful, measurable outcomes for ME/CFS treatments?